Expression of the calcitonin receptor, calcitonin receptor-like receptor, and receptor activity modifying proteins during osteoclast differentiation
- PMID: 18384073
- DOI: 10.1002/jcb.21674
Expression of the calcitonin receptor, calcitonin receptor-like receptor, and receptor activity modifying proteins during osteoclast differentiation
Abstract
The expressions of the calcitonin receptor (CTR), the calcitonin receptor-like receptor (CLR), the receptor activity-modifying proteins (RAMP) 1-3, and of the receptor component protein (RCP) have been studied in mouse bone marrow macrophages (BMM) during osteoclast differentiation, induced by treatment with M-CSF and RANKL. Analyses of mRNA showed that CLR and RAMP1-3, but not CTR, were expressed in M-CSF stimulated BMM. RANKL gradually increased CTR mRNA, transiently enhanced CLR and transiently decreased RAMP1 mRNA, but did not affect RAMP2, RAMP3, or RCP mRNA. However, RANKL did not affect protein levels of CLR or RAMP1-3 as assessed by Western blots or FACS analyses, whereas immunocytochemistry showed enhanced CTR protein. Analyses of cAMP production showed that BMM cells expressed functional receptors for calcitonin gene-related peptide (CGRP), amylin, adrenomedullin, and intermedin, but not for calcitonin and calcitonin receptor stimulating peptide (CRSP), but that RANKL induced the expression of receptors for calcitonin and CRSP as well. Calcitonin, CGRP, amylin, adrenomedullin, intermedin, and CRSP all down regulated the CTR mRNA, but none of the peptides caused any effects on the expression of CLR or any of the RAMPs. Our data show that BMM cells express receptors for CGRP, amylin, adrenomedullin, and intermedin and that RANKL induces the formation of receptors for calcitonin and CRSP in these cells. We also show, for the first time, that the CTR is not only down regulated by signaling through the CTR but also by the peptides signaling through CLR/RAMPs.
Similar articles
-
The role of peptides and receptors of the calcitonin family in the regulation of bone metabolism.Bone. 2008 Nov;43(5):813-8. doi: 10.1016/j.bone.2008.07.003. Epub 2008 Jul 18. Bone. 2008. PMID: 18687416 Review.
-
Comparisons between the effects of calcitonin receptor-stimulating peptide and intermedin and other peptides in the calcitonin family on bone resorption and osteoclastogenesis.J Cell Biochem. 2011 Nov;112(11):3300-12. doi: 10.1002/jcb.23256. J Cell Biochem. 2011. PMID: 21748786
-
Deletions of genes encoding calcitonin/alpha-CGRP, amylin and calcitonin receptor have given new and unexpected insights into the function of calcitonin receptors and calcitonin receptor-like receptors in bone.J Musculoskelet Neuronal Interact. 2006 Jan-Mar;6(1):87-95. J Musculoskelet Neuronal Interact. 2006. PMID: 16675892 Review.
-
Effects of calcitonin on the function of human osteoclast-like cells formed from CD14-positive monocytes.Cell Mol Biol (Noisy-le-grand). 2006 May 15;52(3):25-31. Cell Mol Biol (Noisy-le-grand). 2006. PMID: 17535751
-
Aspartate(69) of the calcitonin-like receptor is required for its functional expression together with receptor-activity-modifying proteins 1 and -2.Biochem Biophys Res Commun. 2004 Jul 9;319(4):1203-9. doi: 10.1016/j.bbrc.2004.05.103. Biochem Biophys Res Commun. 2004. PMID: 15194494
Cited by
-
Osteoclasts in multiple myeloma are derived from Gr-1+CD11b+myeloid-derived suppressor cells.PLoS One. 2012;7(11):e48871. doi: 10.1371/journal.pone.0048871. Epub 2012 Nov 16. PLoS One. 2012. PMID: 23173040 Free PMC article.
-
Accelerated Development With Increased Bone Mass and Skeletal Response to Loading Suggest Receptor Activity Modifying Protein-3 as a Bone Anabolic Target.Front Endocrinol (Lausanne). 2022 Jan 12;12:807882. doi: 10.3389/fendo.2021.807882. eCollection 2021. Front Endocrinol (Lausanne). 2022. PMID: 35095771 Free PMC article.
-
Calcitonin-gene-related peptide stimulates stromal cell osteogenic differentiation and inhibits RANKL induced NF-kappaB activation, osteoclastogenesis and bone resorption.Bone. 2010 May;46(5):1369-79. doi: 10.1016/j.bone.2009.11.029. Epub 2009 Dec 2. Bone. 2010. PMID: 19962460 Free PMC article.
-
Magnoflorine Suppresses MAPK and NF-κB Signaling to Prevent Inflammatory Osteolysis Induced by Titanium Particles In Vivo and Osteoclastogenesis via RANKL In Vitro.Front Pharmacol. 2020 Apr 2;11:389. doi: 10.3389/fphar.2020.00389. eCollection 2020. Front Pharmacol. 2020. PMID: 32300300 Free PMC article.
-
Osteoclasts Are Required for Hematopoietic Stem and Progenitor Cell Mobilization but Not for Stress Erythropoiesis in Plasmodium chabaudi adami Murine Malaria.Mediators Inflamm. 2016;2016:3909614. doi: 10.1155/2016/3909614. Epub 2016 Jan 21. Mediators Inflamm. 2016. PMID: 26903708 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials